These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37964021)

  • 41. Reclassifying patients with early-stage Hodgkin lymphoma based on functional radiographic markers at presentation.
    Akhtari M; Milgrom SA; Pinnix CC; Reddy JP; Dong W; Smith GL; Mawlawi O; Abou Yehia Z; Gunther J; Osborne EM; Andraos TY; Wogan CF; Rohren E; Garg N; Chuang H; Khoury JD; Oki Y; Fanale M; Dabaja BS
    Blood; 2018 Jan; 131(1):84-94. PubMed ID: 29038339
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic value of metabolic tumour volume on baseline
    Shagera QA; Cheon GJ; Koh Y; Yoo MY; Kang KW; Lee DS; Kim EE; Yoon SS; Chung JK
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1417-1427. PubMed ID: 30941463
    [TBL] [Abstract][Full Text] [Related]  

  • 43.
    Eisazadeh R; Mirshahvalad SA
    Clin Imaging; 2022 Dec; 92():25-31. PubMed ID: 36179394
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Metabolic parameters of pretreatment 2-[
    Li C; Dong Y; Pan Y; Han Y; Zhang J; Luan X; Liu J; Xu X; Guan Z; Wang G; Xu B
    Quant Imaging Med Surg; 2024 Jan; 14(1):604-617. PubMed ID: 38223061
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluating Novel PET-CT Functional Parameters TLG and TMTV in Differentiating Low-grade Versus Grade 3A Follicular Lymphoma.
    Major A; Hammes A; Schmidt MQ; Morgan R; Abbott D; Kamdar M
    Clin Lymphoma Myeloma Leuk; 2020 Jan; 20(1):39-46. PubMed ID: 31761712
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical and prognostic value of tumor volumetric parameters in melanoma patients undergoing
    Reinert CP; Gatidis S; Sekler J; Dittmann H; Pfannenberg C; la Fougère C; Nikolaou K; Forschner A
    Cancer Imaging; 2020 Jul; 20(1):44. PubMed ID: 32631431
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic Significance Of Sequential 18f-fdg Pet/Ct During Frontline Treatment Of Peripheral T Cell Lymphomas.
    Song GY; Jung SH; Ahn SY; Kim M; Ahn JS; Lee JJ; Kim HJ; Moon JB; Yoo SW; Kwon SY; Min JJ; Bom HS; Kang SR; Yang DH
    Korean J Intern Med; 2024 Mar; 39(2):327-337. PubMed ID: 38268194
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic value of tumoral heterogeneity and volumetric parameters as measured by F18-FDG PET/CT in sinonasal cancer.
    Kim BS; Pak K; Yi KI; Kim IJ; Roh HJ; Cho KS
    Eur Arch Otorhinolaryngol; 2017 Mar; 274(3):1437-1443. PubMed ID: 27747383
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of pre-treatment and mid-treatment 18F-FDG PET/CT imaging in evaluating prognosis of peripheral T-cell lymphoma-not otherwise specified (PTCL-NOS).
    Zhang Y; Wang G; Zhao X; Hu Y; Tan Su Yin E; Chen D; Wang H; Zhao K
    BMC Med Imaging; 2021 Oct; 21(1):145. PubMed ID: 34627196
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic Value of Volumetric Parameters Measured by Pretreatment 18F FDG PET/CT in Patients With Cutaneous Malignant Melanoma.
    Son SH; Kang SM; Jeong SY; Lee SW; Lee SJ; Lee J; Ahn BC
    Clin Nucl Med; 2016 Jun; 41(6):e266-73. PubMed ID: 27055144
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic value of
    Lee JR; Almuhaimid TM; Roh JL; Oh JS; Kim SJ; Kim JS; Choi SH; Nam SY; Kim SY
    J Surg Oncol; 2018 Sep; 118(4):644-650. PubMed ID: 30132891
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Artificial intelligence-based, volumetric assessment of the bone marrow metabolic activity in [
    Sachpekidis C; Enqvist O; Ulén J; Kopp-Schneider A; Pan L; Mai EK; Hajiyianni M; Merz M; Raab MS; Jauch A; Goldschmidt H; Edenbrandt L; Dimitrakopoulou-Strauss A
    Eur J Nucl Med Mol Imaging; 2024 Jul; 51(8):2293-2307. PubMed ID: 38456971
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role of
    Yang J; Yan J; Li J; Yang Z; Zhang H; Zhao Q; Xu W
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2022; 41(2):91-99. PubMed ID: 35292144
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tumor metabolic and secondary lymphoid organ metabolic markers on 18F-fludeoxyglucose positron emission tomography predict prognosis of immune checkpoint inhibitors in advanced lung cancer.
    Jin P; Bai M; Liu J; Yu J; Meng X
    Front Immunol; 2022; 13():1004351. PubMed ID: 36341372
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Baseline [
    Yang Q; Luo Y; Zhang Y; Zhang W; Zhou D; Li F
    Eur Radiol; 2022 Aug; 32(8):5568-5576. PubMed ID: 35316362
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Predictive value of Dmax and %ΔSUVmax of
    Dang J; Peng X; Wu P; Yao Y; Tan X; Ye Z; Jiang X; Jiang X; Liu Y; Chen S; Cheng Z
    BMC Med Imaging; 2023 Oct; 23(1):173. PubMed ID: 37907837
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic significance of metabolic tumor volume and total lesion glycolysis in patients with advanced cervical carcinoma.
    Calles-Sastre L; Mucientes-Rasilla J; San-Frutos Llorente LM; Royuela A; Garcia-Espantaleón Navas M; Herrero Gámiz S; Pérez-Medina T
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019; 38(1):17-21. PubMed ID: 30366731
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of volumetric analyses on [
    Lopci E; Mascarin M
    Expert Rev Hematol; 2023; 16(9):629-631. PubMed ID: 37453051
    [No Abstract]   [Full Text] [Related]  

  • 59. The role of F-18 FDG PET/CT in evaluating the impact of HIV infection on tumor burden and therapy outcome in patients with Hodgkin lymphoma.
    Lawal IO; Nyakale NE; Harry LM; Modiselle MR; Ankrah AO; Msomi AP; Mokgoro NP; Boshomane TG; de Wiele CV; Sathekge MM
    Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):2025-2033. PubMed ID: 28660348
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Added prognostic value of molecular imaging parameters over proliferation index in typical lung carcinoid: an [18F]FDG PET/CT and SSTR imaging study.
    Linguanti F; Abenavoli EM; Briganti V; Danti G; Lavacchi D; Matteini M; Vaggelli L; Novelli L; Grosso AM; Mungai F; Mini E; Antonuzzo L; Miele V; Sciagrà R; Berti V
    Ann Nucl Med; 2023 Jan; 37(1):1-9. PubMed ID: 36309948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.